Search results
Florida DOR Proposes Update to Agricultural Real Property Appraisal Guidelines
The National Law Review· 3 days agoRecently, the Florida Department of Revenue (DOR) published a Notice of Proposed Rule for rule...
Star Wars' Most Obscure Alien Has Officially Been Found
Screen Rant· 21 hours agoWhat's the least-known alien species in Star Wars?
JD Supra: Alabama Loses Interest Addback Attack, Yet Again
JD Supra· 2 days agoAlabama’s Department of Revenue (“DOR”) struck out again when it attacked related party interest transactions. BIT 19-890-JP, BIT 19-1091-JP (Ala. Tax Tribunal 2024), the ...
Investigation by special agents leads to business owners arrest, guilty plea, DOR says
WYFF 4 Greenville· 5 days agoFOR THE LATEST ON THE BREAKING NEWS STORY, YOU CAN STAY WITH WYFF NEWS FOUR RIGHT HERE ON AIR AND ON...
Israel Palestinians Lebanon
The Argus-Press· 6 days agoIsraeli honor guard soldiers salute during the funeral Israeli reserve Major Dor Zimel in Even Yehuda, Israel, Monday, April 22, 2024. Zimel , 27, died of his wounds after Iran-backed
FDA Approves ImmunityBio's Bladder Cancer Drug, Stock Rallies
Benzinga via Yahoo Finance· 5 days agoMonday, the FDA approved ImmunityBio Inc’s (NASDAQ:IBRX) Anktiva (N-803, or nogapendekin alfa...
FDA OKs First IL-15 Receptor Agonist for Early Bladder Cancer
MedPage Today· 5 days ago-unresponsive NMIBC with carcinoma in situ with or without papillary tumors. Approval was supported...
Hundreds of bodies discovered in Gaza mass graves
The Telegraph via Yahoo News· 6 days ago...for Palestine refugees in the region,” he said in a statement. 02:25 PM BST Pictured: Israelis mourn death of IDF soldier Shir Sage, centre, fiancee...
Agency that doles out tax credit funds to private schools can’t say how the state money is being...
The Meridian Star· 6 days agoHouse leaders, who say they want to bolster public education spending, have also proposed more than...
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for...
Morningstar· 6 days agoImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Designated an FDA Breakthrough Therapy, the novel immunotherapy ANKTIVA activates the body’s natural killer
